| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/17/2001 | CA2388912A1 6 human secreted proteins |
| 05/17/2001 | CA2388644A1 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387964A1 22 human secreted proteins |
| 05/17/2001 | CA2387959A1 21 human secreted proteins |
| 05/17/2001 | CA2387624A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 05/16/2001 | EP1099443A1 Transplant/implant device and method for its production |
| 05/16/2001 | EP1098906A1 Peptide analogues of pacap |
| 05/16/2001 | EP1098889A1 Substituted piperazones and their therapeutic uses |
| 05/16/2001 | EP1098888A1 Piperazinone derivatives and their uses |
| 05/16/2001 | EP1098884A1 Il-8 receptor antagonists |
| 05/16/2001 | EP1098878A1 Bispiperidines as antithrombotic agents |
| 05/16/2001 | EP1098663A1 Slow release formulations comprising anionic polysaccharide |
| 05/16/2001 | EP1098659A2 Libraries of polyhydroxamates and their analogs |
| 05/16/2001 | EP1098655A2 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 05/16/2001 | EP1098654A1 Antilipemic composition comprising a polysaccharide containing glucuronic acid |
| 05/16/2001 | EP1098640A1 Anti-ulcer composition comprising a polysaccharide containing glucuronic acid |
| 05/16/2001 | CN1295579A Therapeutic uses of keratinocyte growth factor-2 |
| 05/16/2001 | CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor |
| 05/16/2001 | CN1294911A Substituted nitrobenzene derivative for medicine and other use |
| 05/15/2001 | US6232449 Persephin and related growth factors |
| 05/15/2001 | US6232325 Thrombosis therapy |
| 05/15/2001 | US6232323 Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same |
| 05/15/2001 | US6232315 Method for treating inflammatory diseases by administering a thrombin inhibitor |
| 05/15/2001 | CA2072355C Fibrin sealant delivery method |
| 05/15/2001 | CA1341228C Expression of protein c |
| 05/10/2001 | WO2001032910A2 27 human secreted proteins |
| 05/10/2001 | WO2001032900A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 05/10/2001 | WO2001032888A2 Human transferase molecules |
| 05/10/2001 | WO2001032878A2 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | WO2001032867A1 Polypeptides with expanded primary signalling motifs |
| 05/10/2001 | WO2001032866A2 Hybrid adaptor receptors |
| 05/10/2001 | WO2001032851A2 Modular transport systems for molecular substances and production and use thereof |
| 05/10/2001 | WO2001032714A1 Recombinant fusion molecules |
| 05/10/2001 | WO2001032709A2 Polypeptides with non-natural primary signalling motifs |
| 05/10/2001 | WO2001032695A2 MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032677A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | WO2001032675A1 32 human secreted proteins |
| 05/10/2001 | WO2001032674A1 26 human secreted proteins |
| 05/10/2001 | WO2001032662A2 Oxygen containing spirocondensed heterocyclic compounds and pharmaceutical compositions comprising same for partial coordination of calcium |
| 05/10/2001 | WO2001032653A1 Heterocyclic substituted pyrazolones |
| 05/10/2001 | WO2001032639A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 05/10/2001 | WO2001032629A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 05/10/2001 | WO2001032628A1 Cyano compounds as factor xa inhibitors |
| 05/10/2001 | WO2001032618A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 05/10/2001 | WO2001032611A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | WO2001032596A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 05/10/2001 | WO2001032144A1 Dry powder compositions having improved dispersivity |
| 05/10/2001 | WO2001032130A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 05/10/2001 | WO2000078778A3 C-pyrazole a2a receptor agonists |
| 05/10/2001 | WO2000063241A3 Methods and compositions for modulating an immune response |
| 05/10/2001 | DE19953025A1 Pyrrolderivate als Phosphodiesterase VII-Hemmer Pyrrole derivatives as phosphodiesterase VII inhibitor |
| 05/10/2001 | CA2390025A1 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 05/10/2001 | CA2389807A1 Heterocyclic substituted pyrazolones |
| 05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | CA2389644A1 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | CA2389439A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 05/10/2001 | CA2388955A1 Recombinant fusion molecules |
| 05/10/2001 | CA2388822A1 27 human secreted proteins |
| 05/10/2001 | CA2387801A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | CA2387785A1 Human transferase molecules |
| 05/10/2001 | CA2387754A1 10 human secreted proteins |
| 05/10/2001 | CA2387136A1 26 human secreted proteins |
| 05/10/2001 | CA2386641A1 32 human secreted proteins |
| 05/10/2001 | CA2385665A1 Modulation of enos activity and therapeutic uses thereof |
| 05/09/2001 | EP1097945A2 Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| 05/09/2001 | EP1097943A1 Process for the preparation of hyperpolymers of haemoglobin with uniform molecular weight |
| 05/09/2001 | EP1097942A2 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes |
| 05/09/2001 | EP1097920A1 Intermediate for condensed benzazepine derivatives |
| 05/09/2001 | EP1097159A1 Phosphinous and phosphonic acid derivatives used as medicaments |
| 05/09/2001 | EP1097153A1 Novel triazolo[4,5-d]pyrimidine compounds |
| 05/09/2001 | EP1097127A1 Diacylhydrazine derivatives as integrin inhibitors |
| 05/09/2001 | EP1096951A1 Use of bromelain proteases for inhibiting blood coagulation |
| 05/09/2001 | CN1293993A Styptic and inflammation-relieving medicine and its preparing process |
| 05/09/2001 | CN1065438C Cyclic adhesion inhibitors |
| 05/08/2001 | US6228854 Selective factor Xa inhibitors |
| 05/08/2001 | US6228853 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/08/2001 | US6228834 Treating gramnegative bacterial infections; neutralizing lipopolysaccharides |
| 05/08/2001 | US6228617 Nucleotide sequence coding a trigger chaperone protein; for use in screening bactericides |
| 05/08/2001 | US6228613 Stable factor VIII/von Willebrand factor complex |
| 05/08/2001 | US6228360 Immunoglobulins binding to human von willebrand factor with chains |
| 05/08/2001 | CA2095852C Proteins with changed epitopes and methods for the production thereof |
| 05/03/2001 | WO2001031029A2 Human sphingosine kinase gene |
| 05/03/2001 | WO2001031005A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | WO2001030997A2 Microbe, microbial exopolysaccharide, and uses thereof |
| 05/03/2001 | WO2001030996A2 Microbial exopolysaccharide and uses thereof |
| 05/03/2001 | WO2001030969A2 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 05/03/2001 | WO2001030856A1 Molecularly imprinted polymers produced by template polymerisation |
| 05/03/2001 | WO2001030802A2 Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies |
| 05/03/2001 | WO2001030781A2 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION |
| 05/03/2001 | WO2001030780A2 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 05/03/2001 | WO2001030774A1 Substituted indoles for modulating nfkb activity |
| 05/03/2001 | WO2001030767A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 05/03/2001 | WO2001030756A1 Benzamidine derivatives |
| 05/03/2001 | WO2001030367A1 Platelet-activating factor antagonists and dermatological compositions for external use containing the same |
| 05/03/2001 | WO2001030353A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 05/03/2001 | WO2001030333A2 Tissue factor antagonists and methods of use thereof |
| 05/03/2001 | WO2001030300A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |